Rob Cully

Enteral devices section leader at Fresenius Kabi - Bad Homburg, Hessen, DE

Rob Cully's Colleagues at Fresenius Kabi
Chris Kenny

Resource and Capacity Planning Manager

Contact Chris Kenny

Nikki Rigby

Contracts Co-ordinator

Contact Nikki Rigby

Nichola Robinson

Legal Counsel UK and Ireland

Contact Nichola Robinson

Susan Iley

National Sales Manager

Contact Susan Iley

Stefanie Schweighofer

Quality Control - Head of QC Chemistry

Contact Stefanie Schweighofer

Stephan Stoiser

Head of Sales and Marketing AT & SEE (South Eastern Europe)

Contact Stephan Stoiser

View All Rob Cully's Colleagues
Rob Cully's Contact Details
HQ
(496) 172-6860
Location
Company
Fresenius Kabi
Rob Cully's Company Details
Fresenius Kabi logo, Fresenius Kabi contact details

Fresenius Kabi

Bad Homburg, Hessen, DE • 22278 Employees
Major Drugs

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With more than 43,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of almost 450 million patients annually. With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. For more information, please visit www.fresenius-kabi.com. Imprint: https://www.fresenius-kabi.com/imprint

Global Healthcare Medical Technologies Biosimilars Clinical Nutrition Medical Devices Oncology Autoimmune Disease
Details about Fresenius Kabi
Frequently Asked Questions about Rob Cully
Rob Cully currently works for Fresenius Kabi.
Rob Cully's role at Fresenius Kabi is Enteral devices section leader.
Rob Cully's email address is ***@fresenius-kabi.com. To view Rob Cully's full email address, please signup to ConnectPlex.
Rob Cully works in the Major Drugs industry.
Rob Cully's colleagues at Fresenius Kabi are Chris Kenny, Nikki Rigby, Nichola Robinson, Susan Iley, Kelly Phillips, Stefanie Schweighofer, Stephan Stoiser and others.
Rob Cully's phone number is (496) 172-6860
See more information about Rob Cully